FDA warns against risky vein-opening procedure TVAM

CBS News featured UBC research on “liberation therapy,” which is promoted to treat multiple sclerosis, after the Food and Drug Administration warned patients and doctors to avoid the therapy.

The UBC study results showed that the therapy did not lead to a difference in the disease’s progression.

Global also reported on a woman who stands by the therapy.